enteroporc coli ac
ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - Χοίροι - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:- clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6- clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins- clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - Χοίροι - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.
coglavax suspension for injection
ceva sante animale (0000008501) avenue de la ballastiere, libourne, 33500 - clostridium perfringens type a toxoid; clostridium perfringens type c beta toxoid; clostridium perfringens epsilon type d toxoid; clostridium septicum toxoid; clostridium novyi type b alpha toxoid; clostridium tetani toxoid; clostridium chauvoei anaculture - suspension for injection - clostridium perfringens type a toxoid (8900000191) 0mg; clostridium perfringens type c beta toxoid (8000001315) 0mg; clostridium perfringens epsilon type d toxoid (8000001316) 0mg; clostridium septicum toxoid (8000001000) 0mg; clostridium novyi type b alpha toxoid (8000001317) 0mg; clostridium tetani toxoid (8000001002) 0mg; clostridium chauvoei anaculture (8000001004) 0mg - clostridium
suiseng coli / c ενεσιμο εναιωρημα
laboratorios hipra s.a. spain (0000003524) avinguda la selva, 135,17170,amer (girona),es - aluminium hydroxide gel; ginseng; e. coli strain p4 (f6 adhesins); e. coli strain p6 (f4ac adhesins); e. coli ΠΑΡΑΓΟΝΤΑΣ ΠΡΟΣΚΟΛΛΗΣΗΣ Κ88 ab; c. novyi toxoid; b toixoid of c. perfringens type c; escherichia coli (lt) enterotoxin; escherichia coli inactivia f5 (o 101:k99) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - aluminium hydroxide gel 0,50 inj.susp 0; ginseng 4,00 inj.susp 0; e. coli strain p4 (f6 adhesins) 80,00 inj.susp 0; e. coli strain p6 (f4ac adhesins) 78,00 inj.susp 0; e. coli ΠΑΡΑΓΟΝΤΑΣ ΠΡΟΣΚΟΛΛΗΣΗΣ Κ88 ab 65,00 inj.susp 0; c. novyi toxoid 50,00 inj.susp 0; b toixoid of c. perfringens type c 35,00 inj.susp 0; escherichia coli (lt) enterotoxin 55,00 inj.susp 0; escherichia coli inactivia f5 (o 101:k99) 79,00 inj.susp 0 - escherichia + clostridium - Χοίροι - Χρόνοι αναμονής: Χοίροι 0 Ημέρες Κρέας και εδώδιμοι ιστοί
panclostil - ενεσιμο εναιωρημα
ceva sante animale, france (0000004708) ,fr - c. chauvoei whole culture; c. tetani toxoid; c. septicum toxoid; c. perfringens type d (e) toxoid; c. perfringens type a toixoid; b toixoid of c. perfringens type c - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - - - c. chauvoei whole culture 0,00 inj.susp -; c. tetani toxoid 2,50 inj.susp -; c. septicum toxoid 2,50 inj.susp -; c. perfringens type d (e) toxoid 5,00 inj.susp -; c. perfringens type a toixoid 2,00 inj.susp -; b toixoid of c. perfringens type c 10,00 inj.susp - - clostridium - Πρόβατα - Χρόνοι αναμονής: Πρόβατα 0 Ημέρες Κρέας και εδώδιμοι ιστοί, γάλα
covexin 10 ενέσιμο εναιώρημα για πρόβατα και βοοειδή
qi02ab01 qi04ab01 - granted - zoetis hellas s.a. - 8900000191 - clostridium perfringens type a toxoid - 0.5 u+; 8900000192 - clostridium perfringens type b & c (Β) toxoid - 18.2 iu; 8900000193 - clostridium perfringens type d (Ε) toxoid - 5.3 iu; 8900000194 - clostridium chauvoei whole culture - 0 iu; 8000001001 - clostridium novyi toxoid - 3.8 iu; 8000001000 - clostridium septicum toxoid - 4.6 iu; 8000001002 - clostridium tetani toxoid - 4.9 iu; 8000001003 - clostridium sordellii toxoid - 4.4 iu; 8900000195 - clostridium haemolyticum toxoid - 17.4 iu - vaccine - vitatrace nutrition ltd
clostridium vac ενεσιμο εναιωρημα
cz veterinaria s.a., spain (0000010069) la relva s/n,,,36400, porrino, pontevedra,,es - c. sordellii ΑΝΑΤΟΞΊΝΗ Γ. chauvoei ΟΛΌΚΛΗΡΗ ΚΟΥΛΤΟΎΡΑ, c. novyi ΑΝΑΤΟΞΊΝΗ c. septicum ΑΝΑΤΟΞΊΝΗ c. perfringens ΤΎΠΟΥ Α (Ε) ΑΝΑΤΟΞΊΝΗ c. perfringens ΤΎΠΟΥ Β & c (Β) ΑΝΑΤΟΞΊΝΗ c. perfringens ΤΎΠΟΥ Α toixoid - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - c. sordellii toxoid 100,00 inj.susp 0; c. chauvoei whole culture 100,00 inj.susp 0; c. novyi toxoid 3,50 inj.susp 0; c. septicum toxoid 2,50 inj.susp 0; c. perfringens type d (e) toxoid 5,00 inj.susp 0; c. perfringens type b & c (Β) toxoid 10,00 inj.susp 0; c. perfringens type a toixoid 0,30 inj.susp 0 - Βοοειδή; Πρόβατα - Χρόνοι αναμονής: Πρόβατα; Βοοειδή
infanrix ipv hib (πενταπλου εμβολιο) pd.su.in.s
glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - pertussis toxoid (pt); filamentous haemagglutinin (fha); pertactin (69 kda outer membrane protein-69k); diphtheria toxoid, adsorbed; tetanus toxoid; inactivated poliovirus vacc type i; inactivated poliovirus vacc type ii; inactivated poliovirus vacc type iii; conjugate of haemophilus influenzae type b capsular polysaccharide(prp) and tetanus toxoid - pd.su.in.s (ΚΟΝΙΣ ΚΑΙ ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ) - pertussis toxoid (pt) 25mcg; filamentous haemagglutinin (fha) 25mcg; pertactin (69 kda outer membrane protein-69k) 8mcg; diphtheria toxoid, adsorbed 0 => 30iu; tetanus toxoid 0 => 40iu; inactivated poliovirus vacc type i 40du; inactivated poliovirus vacc type ii 8du; inactivated poliovirus vacc type iii 32du; conjugate of haemophilus influenzae type b capsular polysaccharide(prp) and tetanus toxoid 10mcg - hemophilus influenzae b, purified antigen conjugated; diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus
anero (2+10+5)iu/ml ενεσιμο εναιωρημα
ceva sante animale, france (0000004708) ,f - Το c. perfringens ΤΎΠΟΥ Α (Ε) ΑΝΑΤΟΞΊΝΗ c. perfringens ΤΎΠΟΥ Β & c (Β) ΑΝΑΤΟΞΊΝΗ c. perfringens ΤΎΠΟΥ Α toixoid - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - (2+10+5)iu/ml - c. perfringens type d (e) toxoid 5,00 inj.susp (2+10+5)iu/ml; c. perfringens type b & c (Β) toxoid 10,00 inj.susp (2+10+5)iu/ml; c. perfringens type a toixoid 2,00 inj.susp (2+10+5)iu/ml - (2+10+5)iu/ml - Πρόβατα - Χρόνοι αναμονής: Πρόβατα
suiseng ενέσιμο εναιώρημα για χοίρους.
qi09ab08 - granted - laboratorios hipra s.a. - 8900000180 - f4ab fimbrial adhesin of e. coli - 65 % erx; 8900000181 - f4ac fimbrial adhesin of e. coli - 78 % erx; 8900000182 - f5 fimbrial adhesin of e. coli - 79 % erx; 8900000183 - f6 fimbrial adhesin of e. coli - 80 % erx; 8900000184 - lt enterotoxoid of e. coli - 55 % erx; 8900000185 - toxoid clostridium perfrigens, type c - 35 % erx; 8000001001 - clostridium novyi toxoid - 50 % erx - vaccine - premier shukuroglou animal health ltd.